Tag: Merck KGaA

Merck Signed Joint Development Agreement with Rigaku

Rigaku Corporation, a key player in scientific analytical instrumentation, and Merck KGaA, Darmstadt, Germany, a leading science and technology company, have signed a joint development agreement. T...

Merck and Chinese Company to Focus on C&G Therapy

Collaboration to build global-standard platform for plasmid and virus manufacturing in China. Merck, a leading science and technology company, today announced the signing of a non-binding Memorandu...

Merck in Agreement for Using Iktos’ AI Technology

Agreement is part of Merck’s R&D strategy to advance drug discovery with strategic technology-focused collaborations. Merck, a leading science and technology company, announced a collaboration ...

Merck KGaA expands its collaboration with Kuraray Europe

merck-kgaa
Merck KGaA announced it has extended and expanded its collaboration with Kuraray Europe to exclusively supply pharmaceutical polyvinyl alcohol (PVA) grades and improvements.

The Oxford Science Park is to house the Vaccines Manufacturing Innovation Centre

Pharma companies are industrial partners of Britain's first facility dedicated to innovation in vaccines manufacturing. Located on a new plot close to the Magdalen Centre, home to many SMEs, the £6...

Merck KGaA will use a cloud-based in silico proteome screening platform

Merck KGaA
Merck KGaA (Germany), a leading science and technology company, announced that it has entered into a licensing agreement with Cyclica (Canada) for the use of Ligand Express, a cloud-based in silico pr...

Merck KGaA to create a joint venture with US software company

test tube
Merck KGaA (Germany), a leading science and technology company, and software company Palantir Technologies (USA), announced their intent to form a joint venture under the brand name Syntropy.

Merck KGaA to establish an innovation hub in Guangzhou

merck-kgaa
Merck KGaA signed an agreement with the Guangzhou Development District on innovation development in Southern China. Merck KGaA to establish an innovation hub in Guangzhou.

Merck KGaA starts new platform to advance biotherapeutic drug manufacturing

merck kgaa
Merck KGaA launched its new BioContinuum™ Platform to advance biotherapeutic drug manufacturing through improved efficiency, simplified plant operations and greater quality and consistency.

GlycoBac starts new partnership with MilliporeSigma

tubes
GlycoBac, a University of Wyoming spin-out biotechnology company, and MilliporeSigma recently partnered to offer a rhabdovirus-free insect platform for viral vaccines and gene therapy development.

Merck KGaA launched a new packaging center in Darmstadt

merck kgaa
On October 17, Merck KGaA, the vibrant science and technology company, inaugurated a new packaging center at its headquarters in Darmstadt (Germany).

Merck KGaA starts M Lab Collaboration Center in Brazil

merck kgaa
The center will provide Life Science customers with a shared, exploratory environment where they can closely collaborate with Merck scientists and engineers.

Merck KGaA gets hold on $117 million contract for Samsung biosimilar

biosimilars
Merck KGaA, a global health care company, has won a $117 million contract to supply the biosimilar Renflexis, developed by Samsung Bioepis Co., to the U.S. Department of Veterans Affairs.

Merck opens GMP BioReliance testing lab in Singapore

drug-testing
Merck KGaA (Germany) announced the opening of a new 3,800-square-meter laboratory in Singapore. The new $20 million biologics testing facility is the first of its kind in Singapore.

Merck KGaA unveiled three new products for biomanufacturing

merck-kgaa
Merck KGaA (Darmstadt, Germany) launched three new products to help biomanufacturers navigate the evolving biopharma landscape with increased speed, greater flexibility and enhanced quality.

Merck KGaA offers a series of grants to stimulate innovative research

merck kgaa
In celebrating its 350th anniversary, Merck offers a series of research grants to stimulate innovative research in challenging areas of future importance.